A molecule released by muscle during physical activity appears to contribute to the endurance training–typical adaptations. The study, published in Nature Communications, identifies L-β-aminoisobutyric acid (L-BAIBA) as a possible mediator of the muscle’s response to exercise.
A Metabolic Message from the Muscle
During activity, skeletal muscle does not merely consume energy: it generates and releases signals that participate in communication with other tissues. Among these, L-BAIBA emerges as a molecule capable of linking the stimulus of training to structural and functional changes in the muscle.
In animal models, six weeks of BAIBA administration increased mitochondrial function, altered fiber composition, and improved contractile strength. Mice ran faster and logged more laps on the wheel, without increasing the number or duration of spontaneous running: a finding that suggests improved performance rather than heightened motivation to move.
Among the forms examined, L-BAIBA proved most relevant for fiber remodeling, oxidative metabolism, and fatigue resistance. When paired with training, the molecule amplified certain muscular adaptations.
The Role of the PGC-1α–BAIBA–PPARδ Axis
The functional evidence also stems from the opposite experiment: reducing in the muscle the expression of ABAT, the enzyme needed to produce L-BAIBA, led to attenuated training adaptations. After six weeks on a treadmill, the mice showed smaller gains in strength, fatigue resistance, and mitochondrial function.
The proposed mechanism involves the PGC-1α–BAIBA–PPARδ axis: PGC-1α would promote the production of L-BAIBA during exercise, while PPARδ would help translate the signal into skeletal muscle adaptations. In human muscle cells, L-BAIBA modulated markers linked to differentiation and to oxidative metabolism in muscle fibers.
Promising Signals
In volunteers, 45 minutes of aerobic exercise at 60% of VO2 peak increased circulating levels of L-BAIBA; higher resting concentrations were also associated with better aerobic fitness. In a second group, ten weeks of endurance training confirmed the molecule’s rise.
These findings indicate a possible physiological role for L-BAIBA in exercise adaptation, but they do not yet demonstrate a therapeutic effect in humans.
Possible Implications for Diabetes and Muscle Frailty
In a mouse model of obesity and type 2 diabetes, BAIBA improved glucose tolerance, muscle function, and running capacity. The finding opens a research path for conditions characterized by muscle weakness, reduced oxidative capacity, and limited exertional tolerance that affect quality of life.
No “Exercise Pill”
The authors do not show that L-BAIBA can substitute for physical activity or that its administration improves strength or performance in patients.
The clinical takeaway, for now, is more cautious: understanding the molecular signals of exercise could help develop strategies to preserve muscle function in people who cannot train adequately.
Study
Daou, H.N., Watt, N.T., Gad, S.A. et al. The metabokine β-aminoisobutyric acid mediates exercise performance and skeletal muscle adaptation through a PGC1α-BAIBA-PPARδ axis. Nat Commun 17, 8090 (2026). https://doi.org/10.1038/s41467-026-76307-8
Abbonati a Karla Miller
